Secondary Logo

Journal Logo

May 2011 - Volume 21 - Issue 5
pp: 243-311

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

Marciante, Kristin D.; Durda, Jon P.; Heckbert, Susan R.; More

Pharmacogenetics and Genomics. 21(5):280-288, May 2011.

Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C

Doehring, Alexandra; Hofmann, Wolf Peter; Schlecker, Christina; More

Pharmacogenetics and Genomics. 21(5):289-296, May 2011.